There has been incessant rise in prevalence of atrial fibrillation and other heart-related medical conditions such as valvular heart diseases and number of hypertension patients. These factors are primarily attributed to growth of Electrophysiology/Atrial Fibrillation market. The report “Global Electrophysiology/Atrial Fibrillation Ablation Market Outlook 2022” provides an in-depth analysis of global electrophysiology/atrial fibrillation market.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global electrophysiology/atrial fibrillation ablation market. The report has been segmented as following:-
Market Segmentation
• By Products
• EP Ablation Catheters
• EP Diagnostic Catheters
• Cardiac Monitors
• By Application
• EP Monitoring Devices
• EP Treatment Devices
Key Vendors
• Medtronic Plc
• Biosense Webster, Inc.
• Abbott Laboratories
• Boston Scientific Corporation
Electrophysiology is the study of electrical system of the heart in order to determine best treatment option for cardiac arrhythmia. Some of the most common indications where EP is used are Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia (AVNR), Wolff-Parkinson-White Syndrome (WPW), among others. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia characterised by loss of the normal electrical rhythm of the heart. There are two main types of atrial fibrillation-Paroxysmal atrial fibrillation and Persistent or permanent atrial fibrillation. Based on unique needs of patient, cardiologist discusses symptoms with the patient and determine proper treatment based on unique needs of each patient.
Growth of global electrophysiology/atrial fibrillation ablation market is primarily attributed to factors such as higher prevalence of atrial fibrillation, rise in number of hypertension patients, increasing incidence of valvular heart diseases, growing geriatric population and increasing demand for minimally invasive procedure. However, the market faces challenges due to stringent regulatory approval, reimbursement issues, dearth of skilled professionals and treatment skewed towards pharmaceutical intervention. The market is characterized by leading trends such as FIRM-guided ablation for atrial fibrillation, rise in number of mergers and acquisitions and advent of New Oral Anticoagulants (NOACS).
The report “Global Electrophysiology/Atrial Fibrillation Ablation Market Outlook 2022” provides in-depth analysis of the current scenario, detailed market outlook of the global electrophysiology/atrial fibrillation market with coverage on major market segments such as EP Products (EP Ablation Catheters, EP Diagnostic Catheters and Cardiac Monitors) and EP Applications (EP Monitoring Devices and EP Treatment Devices). Future forecasts of Electrophysiology market overall and across various sub-segments is provided in the report till the year 2022. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global electrophysiology/atrial fibrillation ablation market include Medtronic Plc, Biosense Webster, Inc., Abbott Laboratories, Boston Scientific Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global electrophysiology/atrial fibrillation ablation market.
1. Executive Summary
2. Research Methodology
3. Electrophysiology/ Atrial Fibrillation Ablation
3.1 Electrophysiology: Overview
3.2 Indications
3.2.1 Atrial Fibrillation
3.2.2 Atrial Flutter
3.2.3 Atrioventricular Nodal Reentry Tachycardia (AVNR)
3.2.4 Wolff-Parkinson-White Syndrome (WPW)
3.2.5 Others
3.3 Ablation
3.3.1 Overview
3.3.2 Types of Procedure
3.4 Atrial Fibrillation: Overview
3.4.1 Classification of Atrial Fibrillation
3.4.2 Symptoms & Diagnosis of Atrial Fibrillation
3.4.3 Treatment of Atrial Fibrillation
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.1.1 Market Size by Value (Actual & Forecasted)
4.1.2 Market Size by Volume (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Products
4.2.2 Market Share by Application
4.2.3 Market Share by Region
5. Global Electrophysiology Market Segmentation
5.1 Market Segmentation by Products
5.1.1 EP Ablation Catheters
5.1.2 EP Diagnostic Catheter
5.1.3 Cardiac Monitors
5.2 Market Segmentation by Application
5.2.1 EP Monitoring Devices
5.2.2 EP Treatment Devices
6. Market Dynamics
6.1 Industry Trends & Developments
6.1.1 FIRM-Guided Ablation for Atrial Fibrillation
6.1.2 Mergers & Acquisitions
6.1.3 Advent of New Oral Anticoagulants (NOACs)
6.2 Growth Drivers
6.2.1 Higher Prevalence of Atrial Fibrillation
6.2.3 Rise in Number of Hypertension Patients
6.2.4 Increasing Incidence of Valvular Heart Disease
6.2.5 Growing Geriatric Population
6.2.6 Increasing Demand for Minimally Invasive Procedures
6.3 Challenges
6.3.1 Stringent Regulatory Approval
6.3.2 Reimbursement Issues
6.3.3 Dearth of Skilled Professionals
6.3.4 Treatment Skewed towards Pharmaceutical Intervention
7. Competitive Landscape
7.1 Therapeutic Pipeline
7.2 Market Share by Competitors
7.2.1 EP Market Share by Competitors
7.2.2 Market Share by Drugs
8. Company Profile
8.1 Medtronic Plc
8.2 Biosense Webster, Inc.
8.3 Abbott Laboratories
8.4 Boston Scientific Corporation
List of Tables
Table 1: Recent Deals in Global Electrophysiology Market
Table 2: List of New Oral Anticoagulants (NOACs)
Table 3: Global Atrial Fibrillation Market Competitive Landscape
Table 4: Global Electrophysiology Ablation Energy Sources by Key Competitors
Table 5: Global Electrophysiology Market – Independent Companies Analysis
List of Figures
Figure 1: Rockville Research – Research Methodology
Figure 2: Global Ablation Market Share by Procedures (2017)
Figure 3: Global Electrophysiology (AF) Market Size by Value, 2014-17E (US$ Billions)
Figure 4: Global AF Procedure (# of AF Procedures) Mix, 2017-22E (Thousands)
Figure 5: Global Atrial Fibrillation Market Share by Products (2017)
Figure 6: Global Electrophysiology Devices Market Share by Application (2017)
Figure 7: Global Atrial Fibrillation Market Share by Region (2017)
Figure 8: Global Electrophysiology Ablation Catheters Market Size by Value, 2015-22E (US$ Billions)
Figure 9: Global Electrophysiology Diagnostic Catheters Market Size by Value, 2015-22E (US$ Billions)
Figure 10: Global Cardiac Monitors Market Size by Value, 2015-22E (US$ Billions)
Figure 11: Global Electrophysiology Monitoring Devices Market Size by Value, 2012-17E (US$ Millions)
Figure 12: Global Electrophysiology Monitoring Devices Market Size by Value Forecasted, 2018E-22E (US$ Millions)
Figure 13: Global Electrophysiology Treatment Devices Market Size by Value, 2012-17E (US$ Millions)
Figure 14: Global Electrophysiology Treatment Devices Market Size by Value Forecasted, 2018E-22E (US$ Millions)
Figure 15: Global Atrial Fibrillation Population, 2010-16 (Millions)
Figure 16: Number of Hypertension Patients Worldwide, 2010-16 (Millions)
Figure 17: Global Valvular Heart Disease Patients, 2010-16
Figure 18: Age-Related Prevalence of Atrial Fibrillation
Figure 19: Global Ageing (aged 60 years and above) Population, 2012-17 (Millions)
Figure 20: Top Selling Products of Atrial Fibrillation, 2016-22E (Units)
Figure 21: Global Atrial Fibrillation Products Forecasted Revenue Analysis, 2016-23 (US$ Millions)
Figure 22: Global Electrophysiology Market Share by Competitors (2017)
Figure 23: Global Atrial Fibrillation Market Share by Drugs (2017)
Figure 24: Medtronic Plc Net Sales by Business Segment (FY2017)
Figure 25: Medtronic Plc Net Sales, FY2013-FY2017 (US$ Billions)
Figure 26: Biosense Webster, Inc. Net Sales by Business Segment (FY2017)
Figure 27: Biosense Webster, Inc. Net Sales, FY2013-FY2017 (US$ Billions)
Figure 28: Abbott Laboratories Net Sales by Business Segment (FY2017)
Figure 29: Abbott Laboratories Net Sales, FY2013-FY2017 (US$ Billions)
Figure 30: Boston Scientific Corporation Net Sales by Business Segment (FY2017)
Figure 31: Boston Scientific Corporation Net Sales, FY2013-FY2017 (US$ Billions)
Medtronic Plc, Biosense Webster, Inc., Abbott Laboratories, Boston Scientific Corporation
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/global[2] https://www.marketresearchreports.com/pharma-healthcare[3] https://www.marketresearchreports.com/diagnostics[4] https://www.marketresearchreports.com/healthcare[5] https://www.marketresearchreports.com/research-development-pharma-healthcare